Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > tirapazamine

Tirapazamine : Bioreductive agent

CATAPULT Shows Lung Cancer Benefit for Tirapazamine
v.12, no.8 Oncology News (August 1998)
Reports results of CATAPULT-1 (Cisplatin and Tirapazamine Against Previously Untreated Lung Tumors), a phase III study that found the the addition of tirapazamine to cisplatin (Platinol) significantly improves survival in patients with advanced NSCLC (when compared with cisplatin alone), without causing additional myelosuppression. Registration required for free access to [8/98]

Tirapazamine - Recent MEDLINE Abstracts (PubMed)

Tirapazamine Clinical Trials (


Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 18-Feb-2009
Karen Parles, MLS Editor